RS

Ritesh Sharma

Director Director DIN 00988357
DIN 00988357 First appointment Apr 2005 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Ritesh Sharma

Data last updated:

Ritesh Sharma was a Director at Aricent Biotech Private Limited (2016–2017) and Director at Starex Pharma Private Limited (from 2005). The companies operate in Trading.

DIN 00988357
Primary Designation Director
Industry Trading
First Appointment 26 Apr 2005
Oldest Company Age 21 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aricent Biotech Private Limited U74900HR2016PTC058207
Director15 Feb 20162016₹12.1 Lakh (FY 2019)Active
Starex Pharma Private Limited U24232DL2005PTC135369
Director26 Apr 20052005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Starex Pharma Private Limited
Aricent Biotech Private Limited
Premium access

Shareholding and investment profile for Ritesh Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritesh Sharma

Ritesh Sharma was first appointed on 26 Apr 2005 as Director at Starex Pharma Private Limited. The most recent appointment on record is 15 Feb 2016 at Aricent Biotech Private Limited.

Ritesh Sharma held 2 earlier board appointments: Aricent Biotech Private Limited (Director, 15 Feb 2016 to 04 Sep 2017); Starex Pharma Private Limited (Director, from 26 Apr 2005).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available